Study of the effects of AM-1155 in a rat chronic respiratory tract infection model with Pseudomonas aeruginosa.
Sato
A
A
Second Division of Internal Medicine, Hamamatsu University School of Medicine, Japan.
Kitazawa
H
H
Chida
K
K
Hayakawa
H
H
Iwata
M
M
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D007070:Immunoglobulin A / Q000032:analysis; D008168:Lung / Q000382:microbiology; D008221:Lymphoid Tissue / Q000382:microbiology / Q000473:pathology; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D015363:Quinolones / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D007070:Immunoglobulin A; D010879:Piperazines; D015363:Quinolones; D000077734:Gatifloxacin